SEATTLE, November 25, 2021 / PRNewswire / – Coherent Market Insights estimates the global pain management market to be valued at 97,041.9 million by the end of 2028.

Pain management is a branch of medicine that aims to alleviate the suffering caused by chronic pain. The main focus in this area is on improving the quality of life for people suffering from a variety of conditions such as osteoarthritis and back pain. In general, pain management consists of a variety of treatments that involve a multidisciplinary approach and a combination of drugs. Although there are a number of pain relievers, in many cases these treatments are ineffective and can even make the condition worse.

There are several ways to manage pain and find relief. Doctors trained in this specialty may also be able to recommend alternative treatments or prescribe medications that will relieve the patient’s symptoms. A combination of different types of treatment is often most effective. During the consultation, a doctor will keep track of all of your options with you.

Request Sample Copy of This Report @ https://www.coherentmarketinsights.com/insight/request-sample/4626

Market leader:

The increasing number of pain management clinics is expected to fuel the growth of the global pain management drug market during the forecast period. For example in November 2021, Ochsner LSU Health Shreveport, a community health center in the United States, opened a clinic for interventional pain management on the campus of St. Mary Medical Center, Fairfield Medical Office Building.

In addition, it is expected that the availability of new processes will also contribute to the growth of the market. For example in November 2021, NeoSpine, a US-based multidisciplinary spine and pain therapy practice, announced it will offer spinal cord stimulation procedures for the treatment of painful diabetic neuropathy.

Market opportunities

The increase in pain management funding is expected to provide lucrative growth opportunities for players in the global pain management market. For example in November 2021, AppliedVR, a developer of virtual reality therapeutics $ 36 million in Series B funding, increasing the company’s overall increase $ 71 million.

In addition, pain management research and development is expected to provide lucrative growth opportunities for players in the global pain management market. For example in October 2021, Adial Pharmaceuticals Inc. announced data in a preclinical model for pain reduction. Based on the data, Purnovate Inc., a subsidiary of Adial Pharmaceuticals Inc., selected PNV-5030 as the main ingredient in its pain reliever development program.

Market trends

The major players in the global Pain Therapy Market are focused on developing partnership strategies to increase their market share. For example in November 2021, InfuSystem Holdings, Inc. has partnered with a leading US healthcare provider to offer InfuBLOCK, its pain management company.

North America The global pain therapy market is expected to grow significantly due to the increasing number of pain management clinics. For example in October 2021, The Ramos Center for Interventional and Functional Pain Medicine, a United States-based pain management center, has opened a new location in Dunedin, Pinellas County.

Buy This Latest Premium Research Report Now @ https://www.coherentmarketinsights.com/insight/buy-now/4626

Competitive landscape:

Major players in the global Pain Therapy Market include AcelRx Pharmaceuticals, Inc., Averitas Pharma, Inc., AmerisourceBergen, Abbott Laboratories, Allergan, Inc., Cardinal Health, Covidien plc, Durect Corporation, Eli Lilly and Company, Endo Health Solutions, Inc., Forest Laboratories, Inc., GlaxoSmithKline plc, Hospira, Inc., Johnson & Johnson, McKesson Corporation, Merck & Co., Inc., Mundipharma International Ltd., Novartis International AG and Teva Pharmaceuticals.

The major players in the global Pain Therapy Market are focused on merger and acquisition strategies to expand their product portfolios. For example in October 2021, Pacira BioSciences Inc. has agreed to acquire Flexion Therapeutics Inc. to expand its opioid-free pain management offerings.

Key players in the global pain therapy market are also focusing on new product approvals and launches to expand their product portfolios. For example in August 2020, Trevena Inc. received Food and Drug Administration approval for Olinvyk (oliceridine), an opioid agonist used to treat moderate to severe acute pain in adults.

Market segmentation:

According to pain type:

According to drug class:

  • NSAIDs
  • Anesthetics
  • Anticonvulsant
  • Medicines for migraines
  • Antidepressants
  • Opioids
  • Non-narcotic drugs
  • Analgesics

As specified

  • Arthritic pain
  • Neuropathic pain
  • Cancer pain
  • Chronic pain
  • Post-operative pain
  • migraine
  • Fibromyalgia
  • Broken bone
  • Muscle sprain / strain
  • Acute appendicitis
  • Other

Global Pain Therapy Market By Regions:

  • North America
  • Europe
    • By country:
      • United Kingdom
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • the rest of Europe
  • Asia Pacific
    • By country:
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • the rest of Asia Pacific
  • Latin America
    • By country:
      • Brazil
      • Mexico
      • Argentina
      • the rest of Latin America
  • middle East & Africa
    • By country:
      • GCC countries
      • Israel
      • South Africa
      • the rest of middle East & Africa

Would you like more information? Talk to Analyst @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/4626

More related trend reports can be found below:

Eczema Therapeutics Market, By Treatment (Corticosteroids, Emollients / Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics, Immunomodulators, and Interleukin Inhibitors), By Distribution Channel (Hospitals and Clinics, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, middle East, and Africa) – Analysis of size, proportion, prospects and opportunities, 2021-2028

Central Nervous System Diseases Therapeutics Market by Disease Type (Neurovascular Disease, Trauma, Mental Health {Anxiety Disorders, Epilepsy, and Others}, Degenerative Diseases {Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis and Others}, Infectious Diseases, Cancer, and Others), by drug type (analgesics, anesthetics, anti-Parkinson’s drugs, anti-epileptic drugs and others), by distribution channel (hospital pharmacies, retail pharmacies and others) and by region (North America, Latin America, Europe, Asia Pacific, middle East, and Africa) – Analysis of size, proportion, prospects and opportunities, 2021-2028

About us:

Coherent Market Insights is a global research and advisory firm focused on helping our numerous clients achieve transformative growth by helping them make important business decisions. We are headquartered in India, with sales office at Global Financial Capital in the USA and sales consultants in United Kingdom and Japan. Our customer base includes players from various industries in over 57 countries worldwide.

Contact us:
Mr. Shaha
Senior Client Partner – Business Development
Coherent market insights
Phone:
USA: + 1-206-701-6702
UK: + 44-020-8133-4027
Japan: + 81-050-5539-1737
India: + 91-848-285-0837
E-mail: [email protected]
Website: https://www.coherentmarketinsights.com
Follow us: LinkedIn | Twitter

SOURCE Coherent Market Insights